StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note released on Friday. The firm issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Stock Up 1.9 %
Shares of NASDAQ:AEZS opened at $4.24 on Friday. The firm has a fifty day simple moving average of $5.35 and a two-hundred day simple moving average of $6.76. Aeterna Zentaris has a 52 week low of $3.96 and a 52 week high of $12.00. The stock has a market capitalization of $7.60 million, a P/E ratio of -0.29 and a beta of 1.55.
About Aeterna Zentaris
Featured Articles
- Five stocks we like better than Aeterna Zentaris
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Palo Alto Analysts Drive it to New Highs: 50% Upside Is Possible
- Trading Stocks: RSI and Why it’s Useful
- Roblox’s Growth Beyond Kids: Stock Set for Major Moves
- The Most Important Warren Buffett Stock for Investors: His Own
- 5 Oversold Stocks to Buy Right Now
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.